OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Understanding the mechanisms for COVID-19 vaccine’s protection against infection and severe disease
Huijie Yang, Ying Xie, Changgui Li
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 186-192
Open Access | Times Cited: 12
Huijie Yang, Ying Xie, Changgui Li
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 186-192
Open Access | Times Cited: 12
Showing 12 citing articles:
How does the SARS-CoV-2 reinfection rate change over time? The global evidence from systematic review and meta-analysis
Ying Chen, Wenhui Zhu, Xinyue Han, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Ying Chen, Wenhui Zhu, Xinyue Han, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
The effect of COVID-19 vaccine to the Omicron variant in children and adolescents: a systematic review and meta-analysis
Wenting Lu, Shuai Zeng, Yuan Yao, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 6
Wenting Lu, Shuai Zeng, Yuan Yao, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 6
Impact of SARS-CoV-2 inactivated vaccine on symptoms following omicron variant breakthrough infection
Yuqi Zhang, Xinjie Li, Yingxiang Yang, et al.
Vaccine (2025) Vol. 48, pp. 126722-126722
Closed Access
Yuqi Zhang, Xinjie Li, Yingxiang Yang, et al.
Vaccine (2025) Vol. 48, pp. 126722-126722
Closed Access
Differential reactivity of SARS ‐C oV ‐2 S‐protein T‐cell epitopes in vaccinated versus naturally infected individuals
Daniel J. Browne, Pauline Crooks, Corey Smith, et al.
Clinical & Translational Immunology (2025) Vol. 14, Iss. 5
Open Access
Daniel J. Browne, Pauline Crooks, Corey Smith, et al.
Clinical & Translational Immunology (2025) Vol. 14, Iss. 5
Open Access
Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
Marı́a M. Lorenzo, Alejandro Marín-López, Kevin Chiem, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 1006-1006
Open Access | Times Cited: 8
Marı́a M. Lorenzo, Alejandro Marín-López, Kevin Chiem, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 1006-1006
Open Access | Times Cited: 8
Efficacy, immunogenicity, and safety of a monovalent mRNA vaccine, ABO1020, in adults: A randomized, double-blind, placebo-controlled, phase 3 trial
Suad Hannawi, Xiaohong Wu, Ralph Elvi Villalobos, et al.
Med (2024) Vol. 5, Iss. 10, pp. 1282-1292.e3
Open Access | Times Cited: 3
Suad Hannawi, Xiaohong Wu, Ralph Elvi Villalobos, et al.
Med (2024) Vol. 5, Iss. 10, pp. 1282-1292.e3
Open Access | Times Cited: 3
RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia
Teresa Maria Seccia, Tungalagtamir Shagjaa, Margherita Morpurgo, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 20, pp. 6618-6618
Open Access | Times Cited: 7
Teresa Maria Seccia, Tungalagtamir Shagjaa, Margherita Morpurgo, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 20, pp. 6618-6618
Open Access | Times Cited: 7
Vaccinia Virus Strain Mva Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
Marı́a M. Lorenzo, Alejandro Marín-López, Kevin Chiem, et al.
(2023)
Open Access | Times Cited: 6
Marı́a M. Lorenzo, Alejandro Marín-López, Kevin Chiem, et al.
(2023)
Open Access | Times Cited: 6
Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV
Wang-Da Liu, Meng-Shuan Lin, Hsin‐Yun Sun, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 4, pp. 554-563
Open Access
Wang-Da Liu, Meng-Shuan Lin, Hsin‐Yun Sun, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 4, pp. 554-563
Open Access
A Comparison of the Effects of Chlorhexidine and Sodium Bicarbonate Mouthwashes on COVID-19–Related Symptoms
Hanieh Karami, Akram Aarabi, Aygineh Hayrabedian, et al.
Iranian Journal of Nursing and Midwifery Research (2024) Vol. 29, Iss. 1, pp. 60-67
Open Access
Hanieh Karami, Akram Aarabi, Aygineh Hayrabedian, et al.
Iranian Journal of Nursing and Midwifery Research (2024) Vol. 29, Iss. 1, pp. 60-67
Open Access
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy
Claudia Maria Trombetta, Serena Marchi, Margherita Leonardi, et al.
Acta Tropica (2023) Vol. 248, pp. 107042-107042
Open Access | Times Cited: 1
Claudia Maria Trombetta, Serena Marchi, Margherita Leonardi, et al.
Acta Tropica (2023) Vol. 248, pp. 107042-107042
Open Access | Times Cited: 1
Oral complications during the two waves of COVID-19 pandemic in China: a prospective cross-section analysis of 510 cases using questionnaire
Baolin Qu, Honglin Liu, Wanli Zhu, et al.
BMC Oral Health (2024) Vol. 24, Iss. 1
Open Access
Baolin Qu, Honglin Liu, Wanli Zhu, et al.
BMC Oral Health (2024) Vol. 24, Iss. 1
Open Access
Evaluating the accessibility and capacity of SARS-CoV-2 vaccination and analyzing convenience-related factors during the Omicron variant epidemic in Beijing, China
Yuping Duan, Mingyue Jiang, Luodan Suo, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access
Yuping Duan, Mingyue Jiang, Luodan Suo, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access
